Presented By :Syed Faraz RizviMBA-II(Karachi University)
IntroductionVision & Mission StatementCore ValuesProductsSWOT AnalysisAchievementsIndustry InfoCompetitorsMarket ShareFinancial Data
A Global Broad-Based Health Care Company.Founded in USA about 120 years ago.Operating In more than 130 Countries with over70,000 Employees.Business OperationsPharmaceuticalsNutritionalDiagnosticsDiabetes Care
Abbott Pakistan is a part of the GlobalHealth Care Corporation of AbbottLaboratories, Chicago, USA.Started operations in Pakistan in 1948.Along with 1500 Employees with 2Locations Abbott is discovering newMedicinesTechnologiesWaysTo manage „Health‟
“To be a premier healthcarecompany in Pakistan”
„A Promise for Life‟Turning Science into Caring
Pioneering Leading edge Science &CommercializationAchieving World-Class Execution.Caring Making a difference in people‟s lives.Enduring Commitment & purpose.
Manufacturing more than 160 productsA broad range Including Pharmaceutical Products General Health Care Products Nutritional Products Diagnostics Products Diabetes Care
Abbott acquired Knoll BASF Pharma in2000 for $6.9 billion.On June 2005 Abbott achieved class „A‟accreditation against Oliver Wight ABCDchecklist.
StrengthsGood company ReputationStrong Distribution NetworkStrong Brand positioningDeep roots in Pharma businessProfessional Management Team
WeaknessesComparatively High PricesRelying on Imported Raw MaterialLacking of deep rural penetration
OpportunitiesA part of high potential EconomyHigh rate of population increase inPakistanIncreasing Healthcare awareness
ThreatsHigh Inflation rateForeign exchange ratePolitical condition of PakistanGovt restriction on price
The Pakistan pharmaceutical industry meetsaround 70% of the country‟s demand offinished medicineWith an export turnover of over US $ 100million as of 2007.Market Share divided into 59% Local 41%multinational
126.96.36.199.9012345678GSK Highnoon Labs Getz Pharma Abbott LabMarket ShareGSKHighnoon LabsGetz PharmaAbbott Lab59% Local 41% multinationalSOME MAJOR PLAYERS IN PHARMA INDUSTRY